Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research focused on Pseudomonas aeruginosa and Cystic fibrosis, with related work in Staphylococcus aureus, Placebo, Ivacaftor. Notable publications include 'Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor', 'Phase II studies of nebulised Arikace in CF patients with Pseudomonas aeruginosa infection', and 'Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis'.
Prevalence and clinical associations of Staphylococcus aureus small-colony variant respiratory infection in children with cystic fibrosis (SCVSA): a multicentre, observational study
KB001-A, a novel anti-inflammatory, found to be safe and well-tolerated in cystic fibrosis patients infected with Pseudomonas aeruginosa
Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium
Pseudomonas aeruginosa in Cystic Fibrosis Patients With G551D-CFTR Treated With Ivacaftor
<i>Pseudomonas aeruginosa In Vitro</i> Phenotypes Distinguish Cystic Fibrosis Infection Stages and Outcomes
Phase II studies of nebulised Arikace in CF patients with<i>Pseudomonas aeruginosa</i>infection
Staphylococcus aureus Small-Colony Variants Are Independently Associated With Worse Lung Disease in Children With Cystic Fibrosis
Developing an international <i>Pseudomonas aeruginosa</i> reference panel
Progress in cystic fibrosis and the CF Therapeutics Development Network
Pseudomonas aeruginosa isolates of distinct sub-genotypes exhibit similar potential of antimicrobial resistance by drugs exposure